In this lively interview I conducted with Michael Rose, professor of evolutionary biology at the University of California, Irvine, we delve into some pretty heady topics
Liz Parrish, founder of BioViva Sciences discusses the objective improvements in her biomarkers after taking gene therapy for telomerase and follastatin.
Peter Voss explains what adaptive, artificial GENERAL intelligence is. He explains the kinds of cognitive feelings these machines need. Finally, he and Dr. Park explore whether machine intelligence can and should be programmed to value and defend itself.